Kamyar Kalantar-Zadeh M.D. to Hyperphosphatemia
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Hyperphosphatemia.
Connection Strength
6.074
-
Management of serum phosphorus over a 1-year follow-up in patients on peritoneal dialysis prescribed sucroferric oxyhydroxide as part of routine care: a retrospective analysis. BMC Nephrol. 2024 Jun 17; 25(1):197.
Score: 0.879
-
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence. J Nephrol. 2022 04; 35(3):875-888.
Score: 0.747
-
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. J Ren Nutr. 2019 09; 29(5):428-437.
Score: 0.604
-
Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide. Am J Nephrol. 2018; 47(3):153-161.
Score: 0.569
-
Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr. 2013 Nov; 23(6):411-21.
Score: 0.406
-
Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013 Mar; 33(2):180-90.
Score: 0.402
-
Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
Score: 0.399
-
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):842-51.
Score: 0.337
-
Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol. 2010 Apr; 73(4):268-75.
Score: 0.328
-
Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010 Mar; 5(3):519-30.
Score: 0.324
-
Plant-Based Diets for Kidney Disease: A?Guide for Clinicians. Am J Kidney Dis. 2021 02; 77(2):287-296.
Score: 0.170
-
Adequacy of Plant-Based Proteins in Chronic Kidney Disease. J Ren Nutr. 2019 03; 29(2):112-117.
Score: 0.147
-
Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes. Am J Nephrol. 2017; 45(5):431-441.
Score: 0.134
-
Reexamining the Phosphorus-Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status? J Ren Nutr. 2016 05; 26(3):136-40.
Score: 0.123
-
Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. J Am Soc Nephrol. 2015 Jul; 26(7):1671-81.
Score: 0.114
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
Score: 0.084
-
Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol. 2010 Jul; 74(1):12-8.
Score: 0.083
-
Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract. 2009; 113(1):c54-61.
Score: 0.078
-
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story. Am J Kidney Dis. 2009 Feb; 53(2):183-8.
Score: 0.076
-
Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol. 2008; 40(2):427-40.
Score: 0.070